Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Notice Of Work

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Sep 23, 2022 9:31am

72 Views

Post# 34981382

RE:RE:RE:RE:Notice Of Work

The study used current pricing of $5,950/t for BaSO4; we were using $4,940/t in our models in the initiating report in 2020. Note that barite pricing has been relatively stable in the past decade. For pharma products, each tonne of BaSO4 can produce over 100,000 bottles, implying potential revenue of over $400k/t.

https://voyageurpharmaceuticals.ca/wp-content/uploads/2022/03/Voyageur-Mar-2022-Update.pdf

WarrantOfficer wrote: Iscfa: How did you arrive at 12M US dollars? 110M bottles of Smooth X works out to be a little more than a dime for each bottle...

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant